228 related articles for article (PubMed ID: 21478324)
1. CYLD inhibits tumorigenesis and metastasis by blocking JNK/AP1 signaling at multiple levels.
Miliani de Marval P; Lutfeali S; Jin JY; Leshin B; Selim MA; Zhang JY
Cancer Prev Res (Phila); 2011 Jun; 4(6):851-9. PubMed ID: 21478324
[TBL] [Abstract][Full Text] [Related]
2. CYLD inhibits melanoma growth and progression through suppression of the JNK/AP-1 and β1-integrin signaling pathways.
Ke H; Augustine CK; Gandham VD; Jin JY; Tyler DS; Akiyama SK; Hall RP; Zhang JY
J Invest Dermatol; 2013 Jan; 133(1):221-9. PubMed ID: 22832488
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of manganese superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis model.
Zhao Y; Xue Y; Oberley TD; Kiningham KK; Lin SM; Yen HC; Majima H; Hines J; St Clair D
Cancer Res; 2001 Aug; 61(16):6082-8. PubMed ID: 11507057
[TBL] [Abstract][Full Text] [Related]
4. Diallyl trisulfide inhibits phorbol ester-induced tumor promotion, activation of AP-1, and expression of COX-2 in mouse skin by blocking JNK and Akt signaling.
Shrotriya S; Kundu JK; Na HK; Surh YJ
Cancer Res; 2010 Mar; 70(5):1932-40. PubMed ID: 20179211
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic activation of AP1 promotes squamous cell carcinoma metastasis.
Ding X; Pan H; Li J; Zhong Q; Chen X; Dry SM; Wang CY
Sci Signal; 2013 Apr; 6(273):ra28.1-13, S0-15. PubMed ID: 23633675
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin is a potent inhibitor of skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.
Checkley LA; Rho O; Moore T; Hursting S; DiGiovanni J
Cancer Prev Res (Phila); 2011 Jul; 4(7):1011-20. PubMed ID: 21733825
[TBL] [Abstract][Full Text] [Related]
7. Negative regulation of JNK signaling by the tumor suppressor CYLD.
Reiley W; Zhang M; Sun SC
J Biol Chem; 2004 Dec; 279(53):55161-7. PubMed ID: 15496400
[TBL] [Abstract][Full Text] [Related]
8. SAG/ROC2 E3 ligase regulates skin carcinogenesis by stage-dependent targeting of c-Jun/AP1 and IkappaB-alpha/NF-kappaB.
Gu Q; Bowden GT; Normolle D; Sun Y
J Cell Biol; 2007 Sep; 178(6):1009-23. PubMed ID: 17846172
[TBL] [Abstract][Full Text] [Related]
9. Dominant-negative activator protein 1 (TAM67) targets cyclooxygenase-2 and osteopontin under conditions in which it specifically inhibits tumorigenesis.
Matthews CP; Birkholz AM; Baker AR; Perella CM; Beck GR; Young MR; Colburn NH
Cancer Res; 2007 Mar; 67(6):2430-8. PubMed ID: 17363560
[TBL] [Abstract][Full Text] [Related]
10. CYLD: a multifunctional deubiquitinase.
Glittenberg M; Ligoxygakis P
Fly (Austin); 2007; 1(6):330-2. PubMed ID: 18820455
[TBL] [Abstract][Full Text] [Related]
11. AP1 factor inactivation in the suprabasal epidermis causes increased epidermal hyperproliferation and hyperkeratosis but reduced carcinogen-dependent tumor formation.
Rorke EA; Adhikary G; Jans R; Crish JF; Eckert RL
Oncogene; 2010 Nov; 29(44):5873-82. PubMed ID: 20818430
[TBL] [Abstract][Full Text] [Related]
12. Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis.
Jansen AP; Camalier CE; Colburn NH
Cancer Res; 2005 Jul; 65(14):6034-41. PubMed ID: 16024603
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor receptor 1/c-Jun-NH2-kinase signaling promotes human neoplasia.
Zhang JY; Adams AE; Ridky TW; Tao S; Khavari PA
Cancer Res; 2007 Apr; 67(8):3827-34. PubMed ID: 17440097
[TBL] [Abstract][Full Text] [Related]
14. Ochratoxin A-induced cell proliferation and tumor promotion in mouse skin by activating the expression of cyclin-D1 and cyclooxygenase-2 through nuclear factor-kappa B and activator protein-1.
Kumar R; Alam S; Chaudhari BP; Dwivedi PD; Jain SK; Ansari KM; Das M
Carcinogenesis; 2013 Mar; 34(3):647-57. PubMed ID: 23172667
[TBL] [Abstract][Full Text] [Related]
15. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a.
Wen-Sheng W
Oncogene; 2003 Feb; 22(7):955-63. PubMed ID: 12592382
[TBL] [Abstract][Full Text] [Related]
16. CYLD regulates keratinocyte differentiation and skin cancer progression in humans.
Alameda JP; Fernández-Aceñero MJ; Moreno-Maldonado R; Navarro M; Quintana R; Page A; Ramírez A; Bravo A; Casanova ML
Cell Death Dis; 2011 Sep; 2(9):e208. PubMed ID: 21900959
[TBL] [Abstract][Full Text] [Related]
17. Activator protein-1 activity regulates epithelial tumor cell identity.
Gerdes MJ; Myakishev M; Frost NA; Rishi V; Moitra J; Acharya A; Levy MR; Park SW; Glick A; Yuspa SH; Vinson C
Cancer Res; 2006 Aug; 66(15):7578-88. PubMed ID: 16885357
[TBL] [Abstract][Full Text] [Related]
18. IL-1 alpha, innate immunity, and skin carcinogenesis: the effect of constitutive expression of IL-1 alpha in epidermis on chemical carcinogenesis.
Murphy JE; Morales RE; Scott J; Kupper TS
J Immunol; 2003 Jun; 170(11):5697-703. PubMed ID: 12759452
[TBL] [Abstract][Full Text] [Related]
19. c-Jun promotes whereas JunB inhibits epidermal neoplasia.
Jin JY; Ke H; Hall RP; Zhang JY
J Invest Dermatol; 2011 May; 131(5):1149-58. PubMed ID: 21289643
[TBL] [Abstract][Full Text] [Related]
20. FRA1 promotes squamous cell carcinoma growth and metastasis through distinct AKT and c-Jun dependent mechanisms.
Zhang X; Wu J; Luo S; Lechler T; Zhang JY
Oncotarget; 2016 Jun; 7(23):34371-83. PubMed ID: 27144339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
